Target intelligence / Profile preview

ATP-binding cassette subfamily A member 7 (ABCA7)

Target
ABCA7
Molecular classification
Transporter, ATP-binding cassette (ABC) transporter, Phospholipid/cholesterol transporter, Membrane protein
01

Overview

ATP-binding cassette subfamily A member 7 (ABCA7) is a large membrane-spanning transporter protein that belongs to the ABC1 subfamily of ATP-binding cassette transporters[1][2][3][4]. ABCA7 functions primarily in lipid homeostasis and is especially important in the immune system, facilitating translocation of phospholipids and possibly cholesterol across cell membranes, as well as promoting phagocytosis of apoptotic cells and amyloid-beta clearance, particularly in microglia and macrophages[1][3]. Genetic variants in ABCA7 are strongly associated with increased risk for late-onset Alzheimer’s disease, likely through altered lipid regulation and impaired clearance of amyloid-beta peptides[2][3]. ABCA7 is mainly expressed in myeloid and lymphoid tissues, including leukocytes, thymus, spleen, and bone marrow[1][3]. Although indirect modulation by statins is documented, there are currently no clinically established drugs that directly target ABCA7. Disruption of ABCA7 function is associated with neurodegeneration and immune defects, cautioning against untargeted modulation in therapeutic development[3].

Other names
ABCA7ABCA-SSNABCX
02

Mechanism of action

Modulation of phospholipid and cholesterol efflux (via ATP hydrolysis) Indirect immunomodulation (by altering phagocytosis and immune cell function) Influence on amyloid-beta clearance and processing

03

Biological functions

Lipid homeostasisPhagocytosis by macrophages and microgliaRegulation of membrane lipid compositionApolipoprotein-mediated phospholipid effluxCeramide homeostasisOrganization of lipid rafts and immune cell surface proteins (e.g., CD1D)Clearance of amyloid-beta peptides
04

Disease associations

Neurodegenerative disease (notably Alzheimer’s disease)Potential roles in lipid dysregulation disordersImmune dysfunction
05

Safety considerations

Genetic loss of function increases risk of Alzheimer’s disease, raising concerns about potential cognitive impact if targeted therapeutically[3]Disruption may impair immune phagocytosis or lipid homeostasis
06

Interacting drugs

Statins (HMG-CoA reductase inhibitors indirectly modulate ABCA7 expression)[3]

1 more in the full profile.

07

Biomarkers

ABCA7 genetic variants as biomarkers of Alzheimer’s disease risk[3]Loss-of-function or damaging mutations linked to increased susceptibility for late-onset Alzheimer’s disease[3]No standard clinical protein biomarker role established

Beyond the preview

Go deeper on ATP-binding cassette subfamily A member 7 (ABCA7).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on ATP-binding cassette subfamily A member 7 (ABCA7).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call